Medpace Holdings Inc vs Synchrony Financial — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Synchrony Financial trades at $71.7 (market cap $24.69B). The key difference: Synchrony Financial is the larger of the two by market cap, and Synchrony Financial pays a 1.63% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | SYF | |
|---|---|---|
Market Cap | $15.08B | $24.69B |
Sector | Technology | Financials |
52-Week High | $620.59 | $88.47 |
52-Week Low | $308.88 | $63.78 |
Enterprise Value | $14.55B | — |
Dividend Yield | — | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →